Currently, there are 1.00B common shares owned by the public and among those 1.00B shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -0.82% and 10.55% over the past three months. EXC shares are trading 16.05% year to date (YTD), with the 12-month market performance up to 21.88% higher. It has a 12-month low price of $34.01 and touched a high of $44.62 over the same period. EXC has an average intraday trading volume of 7.25 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.00%, 8.66%, and 13.58% respectively.
Institutional ownership of Exelon Corp (NASDAQ: EXC) shares accounts for 83.16% of the company’s 1.00B shares outstanding.
It has a market capitalization of $43.91B and a beta (3y monthly) value of 0.40. The stock’s trailing 12-month PE ratio is 17.81, while the earnings-per-share (ttm) stands at $2.45. The company has a PEG of 2.97 and a Quick Ratio of 0.78 with the debt-to-equity ratio at 1.75. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.92% over the week and 1.96% over the month.
Earnings per share for the fiscal year are expected to increase by 6.59%, and 4.97% over the next financial year. EPS should grow at an annualized rate of 6.00% over the next five years, compared to -4.04% over the past 5-year period.
Evercore ISI coverage for the Exelon Corp (EXC) stock in a research note released on January 21, 2025 offered a Outperform rating with a price target of $44. Jefferies was of a view on September 20, 2024 that the stock is Buy, while Mizuho gave the stock Buy rating on January 10, 2024, issuing a price target of $36- $39. Seaport Research Partners on their part issued Neutral rating on January 08, 2024.